Baxter Q2 2021 Earnings Report
Key Takeaways
Baxter International Inc. reported strong second-quarter results, with a 14% increase in worldwide sales to $3.1 billion. U.S. GAAP EPS increased 23% to $0.59, and adjusted EPS increased 25% to $0.80. The company has raised its full-year sales growth expectations to approximately 8% and adjusted EPS to a range of $3.49 to $3.55.
Second-quarter revenue reached $3.1 billion, a 14% increase on a reported basis.
U.S. GAAP earnings per share (EPS) increased 23% to $0.59.
Adjusted EPS rose 25% to $0.80, exceeding previous guidance.
Full-year 2021 sales growth is expected to be approximately 8%.
Baxter
Baxter
Baxter Revenue by Geographic Location
Forward Guidance
Baxter expects full-year 2021 sales growth of approximately 8% on a reported basis and U.S. GAAP earnings of $2.82 to $2.88 per diluted share and adjusted earnings of $3.49 to $3.55 per diluted share.
Positive Outlook
- Full-year 2021 sales growth of approximately 8% on a reported basis
- Full-year 2021 sales growth of 5% to 6% on a constant currency basis
- Full-year 2021 sales growth of 4% to 5% on an operational basis
- Full-year U.S. GAAP EPS of $2.82 to $2.88
- Full-year adjusted EPS of $3.49 to $3.55
Challenges Ahead
- Third-quarter sales growth of approximately 9% on a reported basis
- Third-quarter sales growth of approximately 7% on a constant currency basis
- Third-quarter sales growth of approximately 6% on an operational basis
- Third-quarter U.S. GAAP earnings of $0.79 to $0.81 per diluted share
- Third-quarter adjusted earnings of $0.93 to $0.95 per diluted share
Revenue & Expenses
Visualization of income flow from segment revenue to net income